Monsanto Plans Independence, Announces New Biotech Projects

Monsanto Plans Independence, Announces New Biotech Projects

ST. LOUIS--Monsanto Co. is in the process of spinning off into an independent company, thereby dividing from Pharmacia Corp., according to a July 22 story that appeared in the Chicago Tribune (www.chicagotribune.com). Reportedly, Pfizer Inc. has proposed to buy Pharmacia, which should allow Monsanto to more readily refocus on biotechnology.

Monsanto has two new biotech projects in the pipeline, according to the Tribune. The first is to splice a gene from algae into canola oil, which will reportedly create a canola oil high in heart-healthy omega-3s without the fishy taste. Monsanto's second project is to insert amino acids into soybeans and corn for "ideal" animal feed, according to the Tribune.

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines